Germany · Series A startup

Who invested in Corimmun

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$8.1Mraised across 2 rounds since 2007, from 2 sources

$880KSeed$7.2MSeries A
Latest round
Series A, $7.2MSept 2008
Step-upi
8.2×
Investors
4
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20072008
$880KSeed$7.2MSeries A
First round
Seed, $880K
Jan 2007
Biggest round
$7.2M
Series A · Sept 2008
Between rounds
20 months
from the last two

The rounds

  1. Sept 2008
    Series A$7.2M2 new

    From a historical funding record

  2. Jan 2007

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

The exit

ExitBuyerPriceWhen
AcquiredJanssen, Pharmaceutical Company Of Johnson & JohnsonundisclosedJun 2012

From historical deal records. Wrong? Tell us.

Everyone who backed them

Bayern KapitalGovernment1round
MIG CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Corimmun

Who invested in Corimmun?

Corimmun's investors include High-Tech Gruenderfonds, High-Tech Gründerfonds, Bayern Kapital and MIG Capital.

How much has Corimmun raised?

Corimmun has raised $8.1M across 2 rounds since 2007.

When did Corimmun last raise?

Corimmun's most recent round was a Series A of $7.2M in Sept 2008.

What was Corimmun's biggest round?

Its most recent round, $7.2M in Sept 2008, is also its largest on record.

Who backed Corimmun first?

Corimmun's first round on record, in Jan 2007, was backed by High-Tech Gründerfonds and Bayern Kapital.

What stage is Corimmun at?

Corimmun's latest named round is a Series A, in Sept 2008.

Where is Corimmun based?

Corimmun is based in Germany.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.